On the public citation graph
Selected control events and reporting odds ratio in signal detection methodology
0 signed · 90 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/pds.1001openalex-snapshot
The reporting odds ratio and its advantages over the proportional reporting ratio
inferredcites →https://doi.org/10.1002/pds.1002openalex-snapshot
The reporting odds ratio versus the proportional reporting ratio: ‘deuce’
inferredcites →https://doi.org/10.1002/pds.1003openalex-snapshot
Measuring drug effects means getting a clearer signal
inferredcites →https://doi.org/10.1002/pds.1742openalex-snapshot
Quantitative signal detection using spontaneous ADR reporting
inferredcites →https://doi.org/10.1002/pds.642openalex-snapshot
Drug use investigation (DUI) and prescription‐event monitoring in Japan (J‐PEM)
inferredcites →https://doi.org/10.1002/pds.677openalex-snapshot
Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports
inferredcites →https://doi.org/10.1002/pds.964openalex-snapshot
Comparison of data mining methodologies using Japanese spontaneous reports
inferredcites →https://doi.org/10.1016/s0167-9473(99)00114-0openalex-snapshot
Bayesian neural networks with confidence estimations applied to data mining
inferredcites →https://doi.org/10.1046/j.0306-5251.2001.01501.xopenalex-snapshot
Determinants of signal selection in a spontaneous reporting system for adverse drug reactions
inferredcites →https://doi.org/10.1080/10401230701844612openalex-snapshot
Antipsychotics, Glycemic Disorders, and Life-Threatening Diabetic Events: A Bayesian Data-Mining Analysis of the FDA Adverse Event Reporting System (1968-2004)
inferredcites →https://doi.org/10.1093/oxfordjournals.aje.a113161openalex-snapshot
AN ALTERNATIVE TO THE PROPORTIONATE MORTALITY RATIO
inferredcites →https://doi.org/10.1111/jopenalex-snapshot
Adult sibling experience, roles, relationshhips and future concerns - a review of the literature in learning disabilities
inferredcites →https://doi.org/10.1111/j.1472-8206.2007.00552.xopenalex-snapshot
The application of knowledge discovery in databases to post‐marketing drug safety: example of the WHO database
inferredcites →https://doi.org/10.1136/jech.46.2.174-aopenalex-snapshot
Observation and Inference. An Introduction to the Methods of Epidemiology
inferredcites →https://doi.org/10.2165/00002018-200629050-00003openalex-snapshot
Under-Reporting of Adverse Drug Reactions
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4856228openalex-extracted
Drug-Induced Liver Injury Associated with Alk Inhibitors: A Pharmacovigilance Analysis of the Fda Adverse Event Reporting System (Faers)
inferred← citeshttps://doi.org/10.1002/brb3.71549openalex-snapshot
A Comprehensive Disproportionality Analysis of Drug‐Related Head Injury Reports Using the FAERS Database
inferred← citeshttps://doi.org/10.1002/clt2.12038openalex-snapshot
Anaphylactic risk related to omalizumab, benralizumab, reslizumab, mepolizumab, and dupilumab
inferred← citeshttps://doi.org/10.1002/hsr2.72194openalex-snapshot
Identifying High‐Risk Medications for Drug‐Induced Dystonia: A 20‐Year Retrospective Real‐World Pharmacovigilance Study Based on FAERS
inferred← citeshttps://doi.org/10.1002/jcph.2389openalex-snapshot
An Updated Comprehensive Pharmacovigilance Study of Drug‐Induced Thrombocytopenia Based on FDA Adverse Event Reporting System Data
inferred← citeshttps://doi.org/10.1002/jcph.475openalex-snapshot
Hepatotoxicity associated with agomelatine and other antidepressants: Disproportionality analysis using pooled pharmacovigilance data from the Uppsala Monitoring Centre
inferred← citeshttps://doi.org/10.1002/jcph.662openalex-snapshot
Drug‐Induced Liver Injury Associated With Antidepressive Psychopharmacotherapy: An Explorative Assessment Based on Quantitative Signal Detection Using Different MedDRA Terms
inferred← citeshttps://doi.org/10.1002/pds.3529openalex-snapshot
Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases
inferred← citeshttps://doi.org/10.1007/s10557-020-07110-wopenalex-snapshot
Hemorrhage Risk Profiles among Different Antithrombotic Regimens: Evidence from a Real-World Analysis of Postmarketing Surveillance Data
inferred← citeshttps://doi.org/10.1007/s11096-022-01472-xopenalex-snapshot
Data mining for adverse drug reaction signals of daptomycin based on real-world data: a disproportionality analysis of the US Food and Drug Administration adverse event reporting system
inferred← citeshttps://doi.org/10.1016/j.clml.2019.08.008openalex-snapshot
Mycobacterial Infections With Ruxolitinib: A Retrospective Pharmacovigilance Review
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e37112openalex-snapshot
Safety profile of levonorgestrel intrauterine system: Analysis of spontaneous reports submitted to FAERS
inferred← citeshttps://doi.org/10.1016/j.intimp.2020.106601openalex-snapshot
Colitis following the use of immune checkpoint inhibitors: A real-world analysis of spontaneous reports submitted to the FDA adverse event reporting system
inferred← citeshttps://doi.org/10.1016/j.psychres.2015.07.024openalex-snapshot
Association between haemorrhages and treatment with selective and non-selective serotonergic antidepressants: Possible implications of quantitative signal detection
inferred← citeshttps://doi.org/10.1016/j.psychres.2026.117375openalex-snapshot
Drug-associated bipolar disorder: A disproportionality analysis of the FAERS database
inferred← citeshttps://doi.org/10.1016/j.therap.2022.10.001openalex-snapshot
Risk monitoring and pharmacovigilance of programmed cell death protein 1 / programmed cell death 1 ligand 1 in cancer patients after solid organ transplantation
inferred← citeshttps://doi.org/10.1016/j.waojou.2021.100594openalex-snapshot
Neuropsychiatric side reactions of leukotriene receptor antagonist, antihistamine, and inhaled corticosteroid: A real-world analysis of the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS)
inferred← citeshttps://doi.org/10.1038/s41598-024-74744-3openalex-snapshot
Drug-associated congenital anomalies of the external ear identified in the United States food and drug administration adverse event reporting system database
inferred← citeshttps://doi.org/10.1038/s41598-025-24217-yopenalex-snapshot
A pharmacovigilance study of daptomycin use in infants under 1 year old based on the FDA adverse event reporting system
inferred← citeshttps://doi.org/10.1080/14740338.2021.1933942openalex-snapshot
Clinical profile of acute pancreatitis following treatment with protease inhibitors: a real-world analysis of post-marketing surveillance data
inferred← citeshttps://doi.org/10.1080/14740338.2023.2248876openalex-snapshot
A pharmacovigilance study of adverse event profiles and haemorrhagic safety of bevacizumab based on the FAERS database
inferred← citeshttps://doi.org/10.1080/14740338.2023.2251381openalex-snapshot
Severe cutaneous adverse reactions associated with immune checkpoint inhibitors therapy and anti-VEGF combination therapy: a real-world study of the FDA adverse event reporting system
inferred← citeshttps://doi.org/10.1080/14740338.2023.2278700openalex-snapshot
Drug-induced hypoglycemia: a disproportionality analysis of the FAERS database
inferred← citeshttps://doi.org/10.1080/14740338.2024.2411370openalex-snapshot
Adverse event profiles of drug-induced decreased libido: an assessment of the US food and drug administration Adverse Event Reporting System
inferred← citeshttps://doi.org/10.1080/14740338.2024.2419999openalex-snapshot
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) for gemcitabine
inferred← citeshttps://doi.org/10.1080/14740338.2024.2435431openalex-snapshot
Anaphylactic risk associated with iodinated and gadolinium-based contrast media
inferred← citeshttps://doi.org/10.1080/14740338.2024.2438752openalex-snapshot
Drug-induced hepatitis B virus reactivation: insights from FAERS database analysis
inferred← citeshttps://doi.org/10.1080/14740338.2024.2442023openalex-snapshot
Vancomycin and linezolid: severe cutaneous adverse reactions to drugs
inferred← citeshttps://doi.org/10.1080/14740338.2025.2461203openalex-snapshot
Associations of acute kidney injury with oral anticoagulants: a disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database
inferred← citeshttps://doi.org/10.1080/14740338.2025.2465852openalex-snapshot
Adverse event profiles of CDK4/6 inhibitors: a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database
inferred← citeshttps://doi.org/10.1097/cad.0000000000001191openalex-snapshot
Caution the arrhythmia association with antibody-drug conjugates: a pharmacovigilance study
inferred← citeshttps://doi.org/10.1097/cm9.0000000000001562openalex-snapshot
Assessing taxane-associated adverse events using the FDA adverse event reporting system database
inferred← citeshttps://doi.org/10.1097/md.0000000000048434openalex-snapshot
Drug-induced neutropenia: A comprehensive pharmacovigilance study of the FAERS database
inferred← citeshttps://doi.org/10.1111/j.1365-2125.2011.04087.xopenalex-snapshot
When to publish measures of disproportionality derived from spontaneous reporting databases?
inferred← citeshttps://doi.org/10.1111/jcpt.13701openalex-snapshot
Does eltrombopag lead to thrombotic events? A pharmacovigilance study of the FDA adverse event reporting system
inferred← citeshttps://doi.org/10.1111/jdi.13481openalex-snapshot
Do sodium–glucose cotransporter 2 inhibitors lead to fracture risk? A pharmacovigilance real‐world study
inferred← citeshttps://doi.org/10.1111/jgh.16411openalex-snapshot
A pharmacovigilance study of association between proton‐pump inhibitors and rhabdomyolysis event based on FAERS database
inferred← citeshttps://doi.org/10.1155/2020/3695101openalex-snapshot
Fournier Gangrene Associated with Sodium-Glucose Cotransporter-2 Inhibitors: A Pharmacovigilance Study with Data from the U.S. FDA Adverse Event Reporting System
inferred← citeshttps://doi.org/10.1155/2022/9914931openalex-snapshot
[Retracted] Fetal Congenital Cardiac and Vascular Disorders Associated with Sertraline Treatment during Pregnancy: Analysis of FAERS Data
inferred← citeshttps://doi.org/10.1177/03000605261475733openalex-snapshot
Disproportionality analysis of drug-induced myocarditis: Insights from the Food and Drug Administration Adverse Event Reporting System database
inferred← citeshttps://doi.org/10.1177/10600280231189897openalex-snapshot
A Real-World Disproportionality Analysis of Drug-Induced Immune Hemolytic Anemia in the FDA Adverse Event Reporting System
inferred← citeshttps://doi.org/10.1177/17562864251315137openalex-snapshot
Drug-induced dementia: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
inferred← citeshttps://doi.org/10.1186/s12882-022-02818-3openalex-snapshot
Syndrome of inappropriate antidiuretic hormone secretion is associated with different proton pump inhibitor use: a pharmacovigilance study
inferred← citeshttps://doi.org/10.1186/s12885-025-13614-1openalex-snapshot
Comparisons of adverse events associated with immune checkpoint inhibitors in the treatment of non-small cell lung cancer: a real-world disproportionality analysis based on the FDA adverse event reporting system
inferred← citeshttps://doi.org/10.1186/s13023-024-03294-8openalex-snapshot
Drug-associated porphyria: a pharmacovigilance study
inferred← citeshttps://doi.org/10.1371/journal.pone.0156395openalex-snapshot
Development and Application of an Alert System to Detect Cases of Food Poisoning in Japan
inferred← citeshttps://doi.org/10.1371/journal.pone.0330340openalex-snapshot
Adverse drug events associated with sodium zirconium cyclosilicate: A real-world pharmacovigilance study based on the FAERS database
inferred← citeshttps://doi.org/10.1371/journal.pone.0342548openalex-snapshot
Disproportionality analysis of fondaparinux associated adverse events based on the FDA adverse event reporting system
inferred← citeshttps://doi.org/10.21037/atm-21-4162openalex-snapshot
Hypoglycemia following the use of glucagon-like peptide-1 receptor agonists: a real-world analysis of post-marketing surveillance data
inferred← citeshttps://doi.org/10.21203/rs.3.rs-31947/v1openalex-snapshot
Acute pancreatitis following treatment with protease inhibitors, which may be potential therapeutics for COVID-19: A real-world analysis of postmarketing surveillance data
inferred← citeshttps://doi.org/10.21203/rs.3.rs-3724995/v1openalex-snapshot
Adverse Event Profiles of CDK4/6 inhibitors: A pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
inferred← citeshttps://doi.org/10.21203/rs.3.rs-5171055/v1openalex-snapshot
Safety of infliximab and adalimumab in pediatric inflammatory bowel diseases: a real-world analysis from FAERS database
inferred← citeshttps://doi.org/10.22541/au.170665783.32247565/v1openalex-snapshot
Neuropsychiatric adverse reactions of leukotriene receptor antagonist, antihistamine and inhaled corticosteroid: A real-world analysis of the Food and Drug Administration (FDA) Adverse Event Reporting
inferred← citeshttps://doi.org/10.22541/au.171814874.49151732/v1openalex-snapshot
Glycopeptide antibiotics and DRESS syndrome: a real world study leveraging the FDA Adverse Event Reporting System (FEARS)database
inferred← citeshttps://doi.org/10.24304/kjcp.2025.35.4.234openalex-snapshot
Disproportionality Analysis of Adverse Drug Reactions across NSAID Classes Using the KAERS Database
inferred← citeshttps://doi.org/10.3389/fcvm.2022.966331openalex-snapshot
Drug-induced torsades de pointes: Disproportionality analysis of the United States Food and Drug Administration adverse event reporting system
inferred← citeshttps://doi.org/10.3389/fimmu.2022.778635openalex-snapshot
Neuromuscular junction dysfunctions due to immune checkpoint inhibitors therapy: An analysis of FAERS data in the past 15 years
inferred← citeshttps://doi.org/10.3389/fmed.2026.1832040openalex-snapshot
Generational safety profiles of BTK inhibitors: adverse reaction signals and real-world evidence from the FAERS database
inferred← citeshttps://doi.org/10.3389/fonc.2023.1070343openalex-snapshot
PARP inhibitor-related haemorrhages: What does the real-world study say?
inferred← citeshttps://doi.org/10.3389/fped.2022.896867openalex-snapshot
Stevens-Johnson Syndrome Following Non-steroidal Anti-inflammatory Drugs: A Real-World Analysis of Post-marketing Surveillance Data
inferred← citeshttps://doi.org/10.3389/fphar.2021.750108openalex-snapshot
Kidney Injury Following Ibuprofen and Acetaminophen: A Real-World Analysis of Post-Marketing Surveillance Data
inferred← citeshttps://doi.org/10.3389/fphar.2021.767999openalex-snapshot
Anaphylaxis Associated With Allergen Specific Immunotherapy, Omalizumab, and Dupilumab: A Real World Study Based on the US Food and Drug Administration Adverse Event Reporting System
inferred← citeshttps://doi.org/10.3389/fphar.2022.872854openalex-snapshot
Stevens-Johnson Syndrome Following Vancomycin and Linezolid: A Real-World Analysis of Post-Marketing Surveillance Data
inferred← citeshttps://doi.org/10.3389/fphar.2022.891336openalex-snapshot
Antifungal Drugs and Drug-Induced Liver Injury: A Real-World Study Leveraging the FDA Adverse Event Reporting System Database
inferred← citeshttps://doi.org/10.3389/fphar.2024.1256649openalex-snapshot
Comparison of the safety profiles for pirfenidone and nintedanib: a disproportionality analysis of the US food and drug administration adverse event reporting system
inferred← citeshttps://doi.org/10.3389/fphar.2024.1362484openalex-snapshot
A pharmacovigilance study on antibody-drug conjugate (ADC)-related neurotoxicity based on the FDA adverse event reporting system (FAERS)
inferred← citeshttps://doi.org/10.3389/fphar.2024.1368244openalex-snapshot
A real-world pharmacovigilance analysis for transthyretin inhibitors: findings from the FDA adverse event reporting database
inferred← citeshttps://doi.org/10.3389/fphar.2025.1555955openalex-snapshot
Risk of medication-induced lactic acidosis and hyperlactatemia: a pharmacovigilance study of the United States Food and Drug Administration’s Adverse Event Reporting System database
inferred← citeshttps://doi.org/10.3389/fphar.2026.1852621openalex-snapshot
Muscle toxicity reports in FAERS: a disproportionality analysis with focus on rhabdomyolysis and cross-database assessment
inferred← citeshttps://doi.org/10.3390/ijms18010101openalex-snapshot
Sensitivity of Quantitative Signal Detection in Regards to Pharmacological Neuroenhancement
inferred← citeshttps://doi.org/10.3820/jjpe.25.56openalex-snapshot
1.Spontaneous Report Database and Case-control Studies
inferred← citeshttps://doi.org/10.5530/ijper.58.1s.2openalex-snapshot
Role of Social Media for Drug Safety Signal Detection
inferred← citeshttps://doi.org/10.5772/2616openalex-snapshot
Data Mining Applications in Engineering and Medicine
inferred← citeshttps://doi.org/10.5772/50095openalex-snapshot
Data Mining Techniques in Pharmacovigilance: Analysis of the Publicly Accessible FDA Adverse Event Reporting System (AERS)
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.